An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Uranw, Surendra ^a,b   Hasker, Epco ^b   Roy, Lalita ^a   Meheus, Filip ^b   Das, Murari Lal ^a   Bhattarai, Narayan Raj ^a   Rijal, Suman ^a   Boelaert, Marleen ^b  

^a B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Disease transmission; Kala azar; Nepal; Outbreak; Risk factor; Sand fly infection; Visceral leishmaniasis

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; EPIDEMIC; FEMALE; HUMAN; INFECTION RISK; LEISHMANIA DONOVANI; MAJOR CLINICAL STUDY; MALE; NEPAL; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; POLYMERASE CHAIN REACTION; RESIDENTIAL AREA; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; STRUCTURED INTERVIEW; URBAN AREA; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; DISEASE OUTBREAKS; FEMALE; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; NEPAL; PREVALENCE; RISK FACTORS; RURAL POPULATION; YOUNG ADULT;

EID: 84872323084     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-21     Document Type: Article

References (25)

1. World Health Organisation Control of the leishmaniasis. World Health Organ Tech Rep Ser 2010, 949:186. World Health Organisation.
2. World Health Organisation/TDR Press release for the Elimination of Kala-azar from endemic countries in the South-East Asia region. Health Ministers Sign Memorandum of Understanding 2005, Geneva/New Delhi: WHO, [document on the internet]. Available from: http://www.who.int/tdrold/publications/tdrnews/news75/leish_elimination.htm. (accessed on 17 May 2011), World Health Organisation/TDR.
3. Bista MB. National overview of Kala-azar in Nepal. Kala-azar in Nepal: principals, practices and public health perspectives 1998, 1-5. Kathmandu, Nepal: EDCD/BPKIHS/WHO, Bastola S, Karki P, Rijal S, Gautam A.
4. Bern C, Joshi AB, Jha SN, Das ML, Hightower AW, Thakur GD, Bista MB. Factors associated with visceral leishmaniasis in Nepal: bed-net use is strongly protective. AmJTrop Med Hyg 2000, 63(3-4):184-188.
5. Rijal S, Boelaert M, Regmi S, Karki BMS, Jacquet D, Singh R, Chance ML, Chappuis F, Hommel M, Desjeux P, Van der Stuyft P, Le Ray D, Koirala S. Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal. Trop Med Int Health 2004, 9(6):724-729. 10.1111/j.1365-3156.2004.01251.x, 15189464.
6. Joshi A, Narain JP, Prasittisuk C, Bhatia R, Hashim G, Jorge A, Banjara M, Kroeger A. Can visceral leishmaniasis be eliminated?. J Vector Borne Dis 2008, 45(2):105-111.
7. Boelaert M, Meheus F, Sanchez A, Singh SP, Vanlerberghe V, Picado A, Meessen B, Sundar S. The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India. Trop Med Int Health 2009, 14(6):639-644. 10.1111/j.1365-3156.2009.02279.x, 19392741.
8. Schenkel K, Rijal S, Koirala S, Vanlerberghe V, Van der Stuyft P, Gramiccia M, Boelaert M. Visceral leishmaniasis in south-eastern Nepal: A cross-sectional survey on Leishmania donovani infection and its risk factors. Trop Med Int Health 2006, 11(12):1792-1799. 10.1111/j.1365-3156.2006.01735.x, 17176343.
9. World Health Organization Urbanization: an increasing risk factor for leishmaniasis. Wkly Epidemiol Rec 2002, 44:365-370. World Health Organization.
10. Barnett PG, Singh SP, Bern C, Hightower AW, Sundar S. Virgin soil: the spread of visceral leishmaniasis into Uttar Pradesh, India. AmJTrop Med Hyg 2005, 73(4):720-725.
11. Rijal S, Uranw S, Chappuis F, Picado A, Khanal B, Paudel IS, Andersen EW, Meheus F, Ostyn B, Das ML, Davies C, Boelaert M. Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal. Trop Med Int Health 2010, 15(Suppl.2):21-28.
12. Bhattarai NR, Das ML, Rijal S, Van der Auwera G, Picado A, Khanal B, Roy L, Speybroeck N, Berkvens D, Davies CR, Coosemans M, Boelaert M, Dujardin JC. Natural infection of Phlebotomus argentipes with Leishmania and other trypanosomatid in a visceral leishmaniasis endemic region of Nepal. Trans R Soc Trop Med Hyg 2009, 103(11):1087-1092. 10.1016/j.trstmh.2009.03.008, 19345387.
13. Picado A, Das ML, Kumar V, Kesari S, Dinesh DS Roy L, Rijal S, Das P, Rowland M, Sundar S, Coosemans M, Boelaert M, Davies CR. Effect of Village-wide use of long-lasting insecticidal nets on Visceral Leishmaniasis vector in India and Nepal: A cluster Randomized Trial. PLoS Negl Trop Dis 2010, 49(1):e587.
14. Peak J, Rana S, Rai LB. HIV and injecting drug use in selected sites of Terai, Nepal 2001, 13-15. Asian Harm Reduction Network and Family Health International Report.
15. Government of Nepal, Ministry of Health and Population National health profile of Nepal 2004, 1-5. Report of USAID/National centre for AIDS and STDs control in Nepal, Government of Nepal, Ministry of Health and Population.
16. Desjeux P. Human leishmaniasis: epidemiology and public health aspects. World Health Stat Q 1992, 45(2-3):267-275.
17. Molina R, Gradoni L, Alvar J. HIV and the Transmission of Leishmania. Ann Trop Med Parasitol 2003, 97(Suppl. 1):S29-S45.
18. Boelaert M, Rijal S, Regmi S, Singh R, Karki B, Jacquet D, Chappuis F, Campino L, Desjeux P, Le Ray D, Koirala S, Van der Stuyft P. A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis. AmJTrop Med Hyg 2004, 70(1):72-77.
19. Rijal S, Yardley V, Chappuis F, Decuypere S, Khanal B, Singh R, Boelaert M, De Doncker S, Croft S, Dujardin JC. Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?. Microbes Infect 2007, 9(4):529-535. 10.1016/j.micinf.2007.01.009, 17350306.
20. Rijal S, Bhandari S, Koirala S, Singh R, Khanal B, Loutan L, Dujardin JC, Boelaert M, Chappuis F. Clinical risk factors for therapeutic failure in Kala-azar patients treated with pentavalent antimonial in Nepal. Trans R Soc Trop Med Hyg 2010, 104(3):225-229. 10.1016/j.trstmh.2009.08.002, 19726065.
21. Picado A, Das ML, Kumar V, Dinesh DS, Rijal S, Singh SP, Das P, Coosemans M, Boelaert M, Davies C. Phlebotomus argentipes seasonal pattern in India and Nepal. J Med Entomol 2010, 47(2):283-286. 10.1603/ME09175, 20380311.
22. Dinesh DS, Das P, Picado A, Davies C, Speybroeck N, Boelaert M, Coosemans M. The efficacy of indoor CDC light traps for collecting the sand fly Phlebotomus argentipes, vector of Leishmania donovani. Med Vet Entomolol 2008, 22(2):120-123.
23. Cerbino Neto J, Loureiro Werneck G, Henrique Nery Costa C. Factors associated with the incidence of urban visceral leishmaniasis: an ecological study in Teresina, Piaui State, Brazil. Cad Saude Publica 2009, 25(7):1543-1551. 10.1590/S0102-311X2009000700012, 19578575.
24. Albuquerque PL, Silva Júnior GB, Freire CC, Oliveira SB, Almeida DM, Silva HF, Cavalcante Mdo S, Sousa Ade Q. Urbanization of visceral leishmaniasis (Kala-azar) in Fortaleza, Ceará, Brazil. Pan Am J Public Health 2009, 26(4):330-333.
25. Raina S, Mahesh DM, Kaul R, Satindera KS, Gupta D, Sharma A, Thakur S. A new focus of visceral leishmaniasis in the Himalayas, India. J Vector Borne Dis 2009, 46(4):303-306.